A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
Clinical trial NCT02688933 · COMPLETED
Trial details
- NCT number
- NCT02688933
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-05
- Primary completion
- 2017-06-19
- Enrollment
- 638
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.